The Presumptive in Serbian and Croatian: A Comparison with Bulgarian in a Broader Balkan Context
Journal of Bulgarian Language · 30.04.2026 · 73 (PRIL) · 351-365
DOI: 10.47810/bl.73.26.pr.20 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Bulgarian Language, online erschienen am 30.04.2026. Verfasst von Martin Stefanov.
Abstract (Originalsprache)
This study examines the grammatical representation of the presumptive in the spirit of Georgi Gerdzhikov’s theory, which treats it as a bipropositional category reflecting the relationship between two predicative nuclei (or the circumstances surrounding them). Presumptive utterances, arising from the speaker’s incomplete knowledge, ex-press a probabilistic relation between two opposing propositions, marking one as more credible (more probable). Building on the limited literature in Serbian linguistics, this study presents the first attempt to approach the topic within the context of Croatian. It explores the specific features of the presumptive in Serbian and Croatian with regard to its development, semantics, and paradigmatic and syntagmatic behaviour. The analysis compares these features with Bulgarian and situates them within a broader Balkan context, taking into account the particularities of the category in the languages of the Balkan Sprachbund.
Zitieren
APA
Stefanov, M. (2026). The Presumptive in Serbian and Croatian: A Comparison with Bulgarian in a Broader Balkan Context. Journal of Bulgarian Language, 73(PRIL), 351-365. https://doi.org/10.47810/bl.73.26.pr.20
Vancouver
Stefanov M. The Presumptive in Serbian and Croatian: A Comparison with Bulgarian in a Broader Balkan Context. Journal of Bulgarian Language. 2026;73(PRIL):351-365. doi:10.47810/bl.73.26.pr.20
BibTeX
@article{Stefanov2026,
author = {Stefanov, Martin},
title = {The Presumptive in Serbian and Croatian: A Comparison with Bulgarian in a Broader Balkan Context},
journal = {Journal of Bulgarian Language},
year = {2026},
volume = {73},
number = {PRIL},
pages = {351--365},
doi = {10.47810/bl.73.26.pr.20}
}
EUVIMED